RNAi joins the singles club

Molecular Therapy

Volumn 20, Issue 11, 2012, Pages 2010-2011

  Peschansky, Veronica J ^a   Liang, Zicai ^b   Wahlestedt, Claes ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b PEKING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; ARGONAUTE 2 PROTEIN; HUNTINGTIN; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; RIBONUCLEASE H; RNA INDUCED SILENCING COMPLEX; SINGLE STRANDED RNA; SINGLE STRANDED SMALL INTERFERING RNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

CAG REPEAT; GENE EXPRESSION; GENE SILENCING; HUNTINGTIN GENE; HUNTINGTON CHOREA; NOTE; PTEN GENE; RNA INTERFERENCE;

EID: 84869011885     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2012.218     Document Type: Note

References (14)

1. Lima, WF, Prakash, TP, Murray, HM, Kinberger, GA, Li, W, Chappell, AE et al. (2012). Single-stranded siRNAs activate RNAi in animals. Cell 150: 883-894.
2. Yu, D, Pendergraff, H, Liu, J, Kordasiewicz, HB, Cleveland, DW, Swayze, EE et al. (2012). Single-stranded RNAs use RNAi to potently and allele-selectively Inhibit mutant Huntingtin expression. Cell 150: 895-908.
3. Kole, R, Krainer, AR and Altman, S (2012). RNA therapeutics: beyond RNA interference and antisense oligonucleotides. Nat Rev Drug Discov 11: 125-140.
4. Bennett, CF and Swayze, EE (2010). RNA targeting therapeutics: Molecular mechanisms of antisense oligonucleotides as a therapeutic platform. Annu Rev Pharmacol Toxicol 50: 259-293.
5. Dias, N and Stein, CA (2002). Antisense oligonucleotides: basic concepts and mechanisms. Mol Cancer Ther 1: 347-355.
6. Chu, CY and Rana, TM (2008). Potent RNAi by short RNA triggers. RNA 14: 1714-1719.
7. Chang, CI, Yoo, JW, Hong, SW, Lee, SE, Kang, HS, Sun, X et al. (2009). Asymmetric shorter-Duplex siRNA structures trigger efficient gene silencing with reduced nonspecific effects. Mol Ther 17: 725-732.
8. de Mezer, M, Wojciechowska, M, Napierala, M, Sobczak, K and Krzyzosiak, WJ (2011). Mutant CAG repeats of Huntingtin transcript fold into hairpins, form nuclear foci and are targets for RNA interference. Nucleic Acids Res 39: 3852-3863.
9. Martinez, J, Patkaniowska, A, Urlaub, H, Luhrmann, R and Tuschl, T (2012). Single-stranded antisense siRNAs guide target RNA cleavage in RNAi. Cell 110: 563-574.
10. Holen, T, Amarzguioui, M, Babaie, E and Prydz, H (2003). Similar behaviour of single-strand and doublestrand siRNAs suggests they act through a common RNAi pathway. Nucleic Acids Res 31: 2401-2407. (Pubitemid 37442108)
11. Xu, Y, Linde, A, Larsson, O, Thormeyer, D, Elmen, J, Wahlestedt, C et al. (2004). Functional comparison of single- and double-stranded siRNAs in mammalian cells. Biochem Biophys Res Commun 316: 680-687. (Pubitemid 38368006)
12. Kanasty, RL, Whitehead, KA, Vegas, AJ and Anderson, DG (2012). Action and reaction: The biological response to siRNA and its delivery vehicles. Mol Ther 20: 513-524.
13. Mestre, TA and Ferreira, JJ (2012). An evidence-based approach in the treatment of Huntington's disease. Parkinsonism Relat Disord 18: 316-320.
14. Burnett, JC and Rossi, JJ (2012). RNA-based therapeutics: Current progress and future prospects. Chem Biol 19: 60-71.